Abstract
In 1991, consensus guidelines recommended psoralen plus ultraviolet A photochemotherapy (PUVA) for those requiring second-line therapy for psoriasis. Narrowband (TL-01) UVB has since become more widely available, replacing the less effective broadband sources. Objectives To compare the efficacy of TL-01 UVB phototherapy and trimethoxypsoralen (TMP) bath-PUVA for chronic plaque psoriasis.
| Original language | English |
|---|---|
| Pages (from-to) | 1194-1204 |
| Number of pages | 11 |
| Journal | The British journal of dermatology |
| Volume | 148 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2003 |
Keywords
- Ultraviolet Rays
- Patient Satisfaction
- Humans
- Aged
- PUVA Therapy
- Photosensitizing Agents
- Ficusin
- Psoriasis
- Balneology
- Adult
- Treatment Outcome
- Follow-Up Studies
- Middle Aged
- Female
- Male
Fingerprint
Dive into the research topics of 'A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver